These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14671219)

  • 1. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
    Bonnema SJ; Nielsen VE; Hegedüs L
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6113-4; author reply 6114-5. PubMed ID: 14671219
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin?
    Huysmans DA; Nieuwlaat WA; Hermus AR
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):297-9. PubMed ID: 15008993
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH.
    Cardia MS; Rubio IG; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):474. PubMed ID: 16584523
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
    Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
    Paz-Filho GJ; Mesa CO; Carvalho GA; Goedert CA; Graf H
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):345-6. PubMed ID: 18167135
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
    Jedrzejuk D; Milewicz A
    Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.
    Nielsen VE; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):655-63. PubMed ID: 15579178
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
    Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Grupe P; Hegedüs L
    Arch Intern Med; 2006 Jul; 166(14):1476-82. PubMed ID: 16864757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radioiodine therapy in benign nodular goitre.
    Bonnema SJ; Fast S; Hegedüs L
    Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):619-31. PubMed ID: 25047210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.
    Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3981-4. PubMed ID: 18664541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.
    Duick DS; Baskin HJ
    Endocr Pract; 2003; 9(3):204-9. PubMed ID: 12917062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
    Medeiros-Neto G; Marui S; Knobel M
    Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
    Barca MF; Gruppi C; Oliveira MT; Romão R; Cárdia MS; Rubio I; Knobel M; Medeiros-Neto G
    Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.